Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $529.70 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $181.86 | 2 | $0 (2024) |
| RxSight Inc | $135.83 | 1 | $0 (2022) |
| Masimo Corporation | $50.04 | 2 | $0 (2024) |
| GENZYME CORPORATION | $36.93 | 1 | $0 (2024) |
| Allergan, Inc. | $32.41 | 2 | $0 (2021) |
| Abbott Laboratories | $24.46 | 1 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $22.44 | 1 | $0 (2018) |
| AbbVie Inc. | $18.19 | 1 | $0 (2023) |
| Sandoz Inc. | $15.16 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $12.38 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $138.77 | 5 | Masimo Corporation ($50.04) |
| 2023 | $42.65 | 2 | Abbott Laboratories ($24.46) |
| 2022 | $281.05 | 2 | ABIOMED ($145.22) |
| 2021 | $16.97 | 1 | Allergan, Inc. ($16.97) |
| 2020 | $15.44 | 1 | Allergan, Inc. ($15.44) |
| 2019 | $12.38 | 1 | Gilead Sciences, Inc. ($12.38) |
| 2018 | $22.44 | 1 | Actelion Pharmaceuticals US, Inc. ($22.44) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Masimo Corporation | SET and rainbow SET (Device) | Food and Beverage | Cash or cash equivalent | $28.89 | General |
| Category: Devices | ||||||
| 08/22/2024 | Masimo Corporation | SET and rainbow SET (Device) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Devices | ||||||
| 06/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $36.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2024 | Sandoz Inc. | TREPROSTINIL (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/27/2023 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Heart Failure | ||||||
| 08/31/2023 | AbbVie Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: EYE CARE | ||||||
| 06/08/2022 | RxSight Inc | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) | Food and Beverage | In-kind items and services | $135.83 | General |
| Category: Ophthalmology | ||||||
| 05/12/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $145.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/25/2021 | Allergan, Inc. | ALPHAGAN P (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/18/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/14/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.38 | General |
| 12/13/2018 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 104 | 177 | $87,990 | $25,044 |
| 2022 | 5 | 190 | 302 | $147,932 | $42,487 |
| 2021 | 8 | 253 | 466 | $221,547 | $64,462 |
| 2020 | 6 | 276 | 501 | $241,477 | $72,066 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 60 | 124 | $76,012 | $20,397 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 53 | $11,978 | $4,647 | 38.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 90 | 187 | $114,745 | $32,561 | 28.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 69 | $15,881 | $5,570 | 35.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,134 | $2,500 | 35.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 18 | 18 | $8,241 | $1,180 | 14.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 12 | $1,931 | $675.96 | 35.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 106 | 279 | $171,306 | $48,925 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 56 | 86 | $20,038 | $6,923 | 34.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $8,136 | $2,704 | 33.2% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 16 | 16 | $5,264 | $1,897 | 36.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 14 | 16 | $4,400 | $1,449 | 32.9% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 19 | 20 | $9,040 | $1,392 | 15.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 18 | $2,934 | $1,028 | 35.0% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 12 | 13 | $429.00 | $145.60 | 33.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 126 | 310 | $190,340 | $55,359 | 29.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 115 | $26,795 | $9,568 | 35.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 19 | $8,588 | $3,006 | 35.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 18 | 19 | $5,225 | $1,724 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 23 | $3,749 | $1,302 | 34.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 14 | 15 | $6,780 | $1,108 | 16.3% |
About Dr. Christopher Thomas, MD
Dr. Christopher Thomas, MD is a Critical Care Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366486292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Thomas, MD has received a total of $529.70 in payments from pharmaceutical and medical device companies, with $138.77 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($529.70).
As a Medicare-enrolled provider, Thomas has provided services to 823 Medicare beneficiaries, totaling 1,446 services with total Medicare billing of $204,059. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Baton Rouge, LA
- Active Since 06/14/2006
- Last Updated 06/04/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1366486292
Products in Payments
- Impella (Device) $181.86
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $135.83
- SET and rainbow SET (Device) $50.04
- DUPIXENT (Biological) $36.93
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $24.46
- OPSUMIT MACITENTAN (Drug) $22.44
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $18.19
- ALPHAGAN P (Drug) $16.97
- AVYCAZ (Drug) $15.44
- TREPROSTINIL (Drug) $15.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Baton Rouge
Dr. Brad Vincent, M.d, M.D
Critical Care Medicine — Payments: $12,424
Dr. Tarek Abdallah, Md, MD
Critical Care Medicine — Payments: $8,422
Dr. Mohammad Pirzadah, Md, MD
Critical Care Medicine — Payments: $5,121
Dr. Roy Culotta, Md, MD
Critical Care Medicine — Payments: $3,644
Robyn Boedefeld, Md, MD
Critical Care Medicine — Payments: $3,556
Dr. Kevin Reed, Md, MD
Critical Care Medicine — Payments: $1,995